Artemisia capillaris extract protects against bile duct ligation-induced liver fibrosis in rats

Experimental and Toxicologic Pathology

Volumn 65, Issue 6, 2013, Pages 837-844

  Han, Jong Min ^a   Kim, Hyeong Geug ^a   Choi, Min Kyung ^a   Lee, Jong Suk ^b   Lee, Jin Suk ^a   Wang, Jing Hua ^c   Park, Hye Jung ^a   Son, Seung Wan ^d   Hwang, Seock Yeon ^a   Son, Chang Gue ^a  

^a Daejeon University   (South Korea)

^b Gyeonggi Institute of Science and Technology Promotion   (South Korea)

^c Ministry of Education   (South Korea)

^d Korea University   (South Korea)

Author keywords

Artemisia capillaris Thunb; Bile duct ligation; Cholestasis; Liver fibrosis

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ARTEMISIA CAPILLARIS EXTRACT; CATALASE; COLLAGEN TYPE 1; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HYDROXYPROLINE; MALONALDEHYDE; PLATELET DERIVED GROWTH FACTOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; SCLEROPROTEIN; SUPEROXIDE DISMUTASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSFORMING GROWTH FACTOR BETA; URSODEOXYCHOLIC ACID;

ALPHA SMOOTH MUSCLE ACTIN GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTEMISIA; ARTEMISIA CAPILLARIS; ARTICLE; BILE DUCT LIGATION; COLLAGEN METABOLISM; COLLAGEN TYPE IA1 GENE; COLLAGEN TYPE IA2 GENE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; DRUG SCREENING; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; LIVER FIBROSIS; LIVER INJURY; LIVER LEVEL; LIVER PROTECTION; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; RAT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1 GENE; TISSUE INHIBITOR OF METALLOPROTEINASE 1 GENE; TISSUE INHIBITOR OF METALLOPROTEINASE 2 GENE; TRANSFORMING GROWTH FACTOR BETA GENE; TREATMENT DURATION; UPREGULATION;

ARTEMISIA CAPILLARIS THUNB; BILE DUCT LIGATION; CHOLESTASIS; LIVER FIBROSIS;

ANIMALS; ANTIOXIDANTS; ARTEMISIA; CHOLAGOGUES AND CHOLERETICS; CHOLESTASIS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MALE; RATS; RATS, SPRAGUE-DAWLEY; URSODEOXYCHOLIC ACID;

ARTEMISIA CAPILLARIS; RATTUS;

EID: 84880046796     PISSN: 09402993     EISSN: 16181433     Source Type: Journal    
DOI: 10.1016/j.etp.2012.12.002     Document Type: Article

References (47)

1. Abraham S., Hermesz E., Szabo A., Ferencz A., Jancso Z., Duda E., et al. Effects of Kupffer cell blockade on the hepatic expression of metallothionein and heme oxygenase genes in endotoxemic rats with obstructive jaundice. Life Sciences 2012, 90:140-146.
2. Alptekin N., Mehmetcik G., Uysal M., Aykac-toker G. Evidence for oxidative stress in the hepatic mitochondria of bile duct ligated rats. Pharmacological Research 1997, 36:243-247.
3. Bataller R., Brenner D.A. Liver fibrosis. Journal of Clinical Investigation 2005, 115:209-218.
4. Beers R.F., Sizer I.W. A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. Journal of Biological Chemistry 1952, 195:133-140.
5. Bellayr I.H., Mu X., Li Y. Biochemical insights into the role of matrix metalloproteinases in regeneration: challenges and recent developments. Future Medicinal Chemistry 2009, 1:1095-1111.
6. Casini A., Ceni E., Salzano R., Biondi P., Parola M., Galli A., et al. Neutrophil-derived superoxide anion induces lipid peroxidation and stimulates collagen synthesis in human hepatic stellate cells: role of nitric oxide. Hepatology 1997, 25:361-367.
7. Chen W.Y., Chen C.J., Liao J.W., Mao F.C. Chromium attenuates hepatic damage in a rat model of chronic cholestasis. Life Sciences 2009, 84:606-614.
8. Choi J.H., Kim D.W., Yun N., Choi J.S., Islam M.N., Kim Y.S., et al. Protective effects of hyperoside against carbon tetrachloride-induced liver damage in mice. Journal of Natural Products 2011, 74:1055-1060.
9. Cui W., Matsuno K., Iwata K., Ibi M., Matsumoto M., Zhang J., et al. NOX1/nicotinamide adenine dinucleotide phosphate, reduced form (NADPH) oxidase promotes proliferation of stellate cells and aggravates liver fibrosis induced by bile duct ligation. Hepatology 2011, 54:949-958.
10. Dai W.J., Jiang H.C. Advances in gene therapy of liver cirrhosis: a review. World Journal of Gastroenterology 2001, 7:1-8.
11. De Bleser P.J., Xu G., Rombouts K., Rogiers V., Geerts A. Glutathione levels discriminate between oxidative stress and transforming growth factor-beta signaling in activated rat hepatic stellate cells. Journal of Biological Chemistry 1999, 274:33881-33887.
12. De Minicis S., Seki E., Uchinami H., Kluwe J., Zhang Y., Brenner D.A., et al. Gene expression profiles during hepatic stellate cell activation in culture and in vivo. Gastroenterology 2007, 132:1937-1946.
13. Desmet V., Roskams T., Van Eyken P. Ductular reaction in the liver. Pathology, Research and Practice 1995, 191:513-524.
14. Dhiman R.K., Chawla Y.K. Herbal medicines for liver diseases. Digestive Diseases and Sciences 2005, 50:1807-1812.
15. Ellman G.L. Tissue sulfhydryl groups. Archives of Biochemistry and Biophysics 1959, 82:70-77.
16. Faubion W.A., Guicciardi M.E., Miyoshi H., Bronk S.F., Roberts P.J., Svingen P.A., et al. Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. Journal of Clinical Investigation 1999, 103:137-145.
17. Friedman S.L. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008, 134:1655-1669.
18. Fujita M., Shannon J.M., Morikawa O., Gauldie J., Hara N., Mason R.J. Overexpression of tumor necrosis factor-alpha diminishes pulmonary fibrosis induced by bleomycin or transforming growth factor-beta. American Journal of Respiratory Cell and Molecular Biology 2003, 29:669-676.
19. Georgiev P., Jochum W., Heinrich S., Jang J.H., Nocito A., Dahm F., et al. Characterization of time-related changes after experimental bile duct ligation. British Journal of Surgery 2008, 95:646-656.
20. Gross J.B., Reichen J., Zeltner T.B., Zimmermann A. The evolution of changes in quantitative liver function tests in a rat model of biliary cirrhosis: correlation with morphometric measurement of hepatocyte mass. Hepatology 1987, 7:457-463.
21. Haber B., Ferreira C.T., Aw M., Bezerra J., Sturm E., Thompson R., et al. Cholestasis: current issues and plan for the future. Journal of Pediatric Gastroenterology and Nutrition 2008, 47:220-224.
22. Herrmann F., Romero M.R., Blazquez A.G., Kaufmann D., Ashour M.L., Kahl S., et al. Diversity of pharmacological properties in Chinese and European medicinal plants: cytotoxicity, antiviral and antitrypanosomal screening of 82 herbal drugs. Diversity 2011, 3:547-580.
23. Hong J.H., Hwang E.Y., Kim H.J., Jeong Y.J., Lee I.S. Artemisia capillaris inhibits lipid accumulation in 3T3-L1 adipocytes and obesity in C57BL/6J mice fed a high fat diet. Journal of Medicinal Food 2009, 12:736-745.
24. Hong J.H., Lee I.S. Effects of Artemisia capillaris ethyl acetate fraction on oxidative stress and antioxidant enzyme in high-fat diet induced obese mice. Chemico-Biological Interactions 2009, 179:88-93.
25. Iredale J.P. Hepatic stellate cell behavior during resolution of liver injury. Seminars in Liver Disease 2001, 21:427-436.
26. Jang G. Jung gyeong jeon seo 1975, Hollym Corp. Publishers, Seoul.
27. Jang S.I., Kim Y.J., Kim H.J., Lee J.C., Kim H.Y., Kim Y.C., et al. Scoparone inhibits PMA-induced IL-8 and MCP-1 production through suppression of NF-kappaB activation in U937 cells. Life Sciences 2006, 78:2937-2943.
28. Koo H.N., Hong S.H., Jeong H.J., Lee E.H., Kim N.G., Choi S.D., et al. Inhibitory effect of Artemisia capillaris on ethanol-induced cytokines (TNF-alpha, IL-1alpha) secretion in Hep G2 cells. Immunopharmacology and Immunotoxicology 2002, 24:441-453.
29. Lee H.S., Kim H.H., Ku S.K. Hepatoprotective effects of Artemisiae capillaris herba and Picrorrhiza rhizoma combinations on carbon tetrachloride-induced subacute liver damage in rats. Nutrition Research 2008, 28:270-277.
30. Lee T.Y., Chang H.H., Chen J.H., Hsueh M.L., Kuo J.J. Herb medicine Yin-Chen-Hao-Tang ameliorates hepatic fibrosis in bile duct ligation rats. Journal of Ethnopharmacology 2007, 109:318-324.
31. Levitan I., Volkov S., Subbaiah P.V. Oxidized LDL: diversity, patterns of recognition, and pathophysiology. Antioxidants and Redox Signalling 2010, 13:39-75.
32. Liu T.Z., Lee K.T., Chern C.L., Cheng J.T., Stern A., Tsai L.Y. Free radical-triggered hepatic injury of experimental obstructive jaundice of rats involves overproduction of proinflammatory cytokines and enhanced activation of nuclear factor kappaB. Annals of Clinical and Laboratory Science 2001, 31:383-390.
33. Mase A., Makino B., Tsuchiya N., Yamamoto M., Kase Y., Takeda S., et al. Active ingredients of traditional Japanese (kampo) medicine, inchinkoto, in murine concanavalin A-induced hepatitis. Journal of Ethnopharmacology 2010, 127:742-749.
34. Mihara M., Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Analytical Biochemistry 1978, 86:271-278.
35. Mormone E., George J., Nieto N. Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches. Chemico-Biological Interactions 2011, 193:225-231.
36. Paumgartner G., Pauletzki J., Sackmann M. Ursodeoxycholic acid treatment of cholesterol gallstone disease. Scandinavian Journal of Gastroenterology. Supplement 1994, 204:27-31.
37. Pinzani M., Rombouts K. Liver fibrosis: from the bench to clinical targets. Digestive and Liver Disease 2004, 36:231-242.
38. Poli G. Pathogenesis of liver fibrosis: role of oxidative stress. Molecular Aspects of Medicine 2000, 21:49-98.
39. Poli G., Schaur R.J. 4-Hydroxynonenal in the pathomechanisms of oxidative stress. IUBMB Life 2000, 50:315-321.
40. Saito J.M., Maher J.J. Bile duct ligation in rats induces biliary expression of cytokine-induced neutrophil chemoattractant. Gastroenterology 2000, 118:1157-1168.
41. Sanchez A., Alvarez A.M., Benito M., Fabregat I. Cycloheximide prevents apoptosis, reactive oxygen species production, and glutathione depletion induced by transforming growth factor beta in fetal rat hepatocytes in primary culture. Hepatology 1997, 26:935-943.
42. Schmucker D.L., Ohta M., Kanai S., Sato Y., Kitani K. Hepatic injury induced by bile salts: correlation between biochemical and morphological events. Hepatology 1990, 12:1216-1221.
43. Seo K.S., Jeong H.J., Yun K.W. Antimicrobial activity and chemical components of two plants, Artemisia capillaris and Artemisia iwayomogi, used as Korean herbal Injin. Journal of Ecology and Field Biology 2010, 33:141-147.
44. Sies H. Oxidative stress: oxidants and antioxidants. Experimental Physiology 1997, 82:291-295.
45. Wang J.H., Choi M.K., Shin J.W., Hwang S.Y., Son C.G. Antifibrotic effects of Artemisia capillaris and Artemisia iwayomogi in a carbon tetrachloride-induced chronic hepatic fibrosis animal model. Journal of Ethnopharmacology 2012, 140:179-185.
46. Wang J.H., Shin J.W., Son J.Y., Cho J.H., Son C.G. Antifibrotic effects of CGX, a traditional herbal formula, and its mechanisms in rats. Journal of Ethnopharmacology 2010, 127:534-542.
47. Webster C.R., Anwer M.S. Cyclic adenosine monophosphate-mediated protection against bile acid-induced apoptosis in cultured rat hepatocytes. Hepatology 1998, 27:1324-1331.